1. Rogg, Manuel, Maier, Jasmin I, Dotzauer, Robert, Huber, Tobias B, Schell, Christoph. 2021. SRGAP1 Controls Small Rho GTPases To Regulate Podocyte Foot Process Maintenance. In Journal of the American Society of Nephrology : JASN, 32, 563-579. doi:10.1681/ASN.2020081126. https://pubmed.ncbi.nlm.nih.gov/33514561/
2. Mondal, Chandrani, Gacha-Garay, Majo J, Larkin, Kathryn A, Martin, Benjamin L, Bravo-Cordero, Jose Javier. . A proliferative to invasive switch is mediated by srGAP1 downregulation through the activation of TGF-β2 signaling. In Cell reports, 40, 111358. doi:10.1016/j.celrep.2022.111358. https://pubmed.ncbi.nlm.nih.gov/36130489/
3. Huang, Tingting, Zhou, Yuhang, Zhang, Jinglin, Kang, Wei, To, Ka Fai. 2017. SRGAP1, a crucial target of miR-340 and miR-124, functions as a potential oncogene in gastric tumorigenesis. In Oncogene, 37, 1159-1174. doi:10.1038/s41388-017-0029-7. https://pubmed.ncbi.nlm.nih.gov/29234151/
4. Feng, Yuyang, Feng, Lei, Yu, Di, Zou, Jian, Huang, Zhaohui. 2016. srGAP1 mediates the migration inhibition effect of Slit2-Robo1 in colorectal cancer. In Journal of experimental & clinical cancer research : CR, 35, 191. doi:. https://pubmed.ncbi.nlm.nih.gov/27923383/
5. Li, Qian, Huang, Lei, Ding, Yan, Peng, Wenjie, Zhang, John H. 2023. Recombinant Slit2 suppresses neuroinflammation and Cdc42-mediated brain infiltration of peripheral immune cells via Robo1-srGAP1 pathway in a rat model of germinal matrix hemorrhage. In Journal of neuroinflammation, 20, 249. doi:10.1186/s12974-023-02935-2. https://pubmed.ncbi.nlm.nih.gov/37899442/